Today an agreement with Orthopaedic Synergy announced.
We are proud that they chose OSI to be their partner,’ says George Cipolletti, President of OMNIlife Technology. SOURCE Amedica Corporation.. Amedica, Orthopaedic Synergy sign SiN articulating hip and knee implant JV Development Agreement Amedica Company , a spinal and orthopaedic implant and device company centered on unique silicon nitride ceramic technologies, today an agreement with Orthopaedic Synergy announced, Inc. Amedica is normally a full-line spinal implant firm that owns and markets silicon nitride ceramic systems that are now being utilized in spinal implant applications; however, the unique SiN materials have disruptive features for hip and knee implant applications, aswell. The JV Development Agreement shall allow the development, regulatory distribution and approval of SiN articulating hip and knee implants in the U.S.And that will make treatment with the organic fruit substance less difficult for esophageal cancer sufferers to swallow literally. We hope to have the ability to prevent cancers in humans utilizing a standardized combination of anthocyanins, Dr. Stoner stated in the media discharge. The target is to possibly replace entire berry powder using its active components and figure out improved ways to deliver these elements to tissues, to improve their uptake and efficiency. Ultimately, we desire to check the anthocyanins for efficiency in multiple organ sites in human beings.